PROCEPT BioRobotics (PRCT) Change in Receivables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Change in Receivables data on file, last reported at $13.3 million in Q1 2026.

• On a quarterly basis, Change in Receivables rose 438.94% year-over-year to $13.3 million in Q1 2026; TTM through Mar 2026 was $18.1 million, a 25.41% decrease from a year earlier, with the FY2025 full-year figure at $898000.0, down 97.5% from the prior year.
• Change in Receivables for Q1 2026 stood at $13.3 million, up from -$2.2 million in the prior quarter.
• Over the last five years, Change in Receivables for PRCT reached as high as $14.8 million in Q4 2024 and fell as low as -$3.9 million in Q1 2025.
• Historically, Change in Receivables has averaged $5.5 million across 5 years, with a median of $3.9 million in 2022.
• Across the five-year window, Change in Receivables jumped 631.15% in 2024 and tumbled 150.99% in 2025, its largest moves.
• Year by year, Change in Receivables stood at $2.4 million in 2022, then soared by 465.08% to $13.8 million in 2023, then grew by 7.84% to $14.8 million in 2024, then tumbled by 115.04% to -$2.2 million in 2025, then surged by 697.17% to $13.3 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $13.3 million in Q1 2026, -$2.2 million in Q4 2025, and $4.4 million in Q3 2025.